about
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid ATargeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.IDO induces expression of a novel tryptophan transporter in mouse and human tumor cellsPercutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.Infliximab for IPILIMUMAB-Related Colitis--LetterCirculating melanoma cells and survival in metastatic melanomaPredictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancerSuccessful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis
P50
Q28294740-D9C170D9-C7F4-4315-B689-9E69BBEBF47AQ36132165-E514A046-1FEE-49BF-82FE-F15733516D70Q37012639-D8580C81-BEFF-4540-9995-0BEC4414054FQ39150340-6053A0AD-8350-4F7B-9E62-D80FC26D17C1Q41963936-DD60045F-E7E1-40CC-8B0A-75466AAED49CQ47239043-113FE753-8054-4545-9CFA-892D6E75728CQ58025377-1BEF1DC0-6125-4B75-B469-BF90CEF7A908Q83130894-CDDAB74B-43D0-4B3B-94DC-01440D9A9EF1Q83976005-DE4BBC7B-D8D6-4EBF-8A98-15A21DC90435Q92737089-EE9330EC-4C02-4BE2-A29F-5756F80D7AEA
P50
description
researcher ORCID ID = 0000-0002-8308-3141
@en
wetenschapper
@nl
name
Ioannis Karydis
@ast
Ioannis Karydis
@en
Ioannis Karydis
@es
Ioannis Karydis
@nl
type
label
Ioannis Karydis
@ast
Ioannis Karydis
@en
Ioannis Karydis
@es
Ioannis Karydis
@nl
prefLabel
Ioannis Karydis
@ast
Ioannis Karydis
@en
Ioannis Karydis
@es
Ioannis Karydis
@nl
P106
P31
P496
0000-0002-8308-3141